In vivo exposure to high or low cortisol has biphasic effects on inflammatory response pathways of human monocytes

Anesthesia and Analgesia

Volumn 107, Issue 5, 2008, Pages 1726-1734

  Yeager, Mark P ^a,b   Pioli, Patricia A ^a   Wardwell, Kathleen ^a   Beach, Michael L ^a   Martel, Peter ^a   Lee, Hong K ^a,b   Rassias, Athos J ^a   Guyre, Paul M ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; CORTICOTROPIN; CYTOKINE; ETOMIDATE; GAMMA INTERFERON RECEPTOR 1; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; MESSENGER RNA; MIFEPRISTONE; SODIUM CHLORIDE; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; GLUCOCORTICOID;

ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; DRUG EXPOSURE; DRUG MEGADOSE; DRUG SALIVA LEVEL; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPERCORTISOLISM; IMMUNE RESPONSE; IN VIVO STUDY; MALE; MONOCYTE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RECEPTOR DOWN REGULATION; STEROIDOGENESIS; ADOLESCENT; ADULT; BLOOD; GENETICS; INFLAMMATION; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADRENOCORTICOTROPIC HORMONE; ADULT; ANTI-INFLAMMATORY AGENTS; ETOMIDATE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INFLAMMATION; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MIFEPRISTONE; MONOCYTES; RECEPTORS, GLUCOCORTICOID;

EID: 56149117076     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e3181875fb0     Document Type: Article

References (48)

1. Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis; preliminary report. Mayo Clin Proc 1949;24:181-97
2. Selye H. Role of the hypophysis in the pathogenesis of the diseases of adaptation. Can Med Assoc J 1944;50:426-33
3. Russell JA. Review article: drug therapy - management of sepsis. N Engl J Med 2006;355:1699-713
4. Dombrovskiy V, Martin A, Sunderram J, Paz H. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Crit Care Med 2007;35:1414-5
5. Selye H, Dosne C, Bassett L, Whittaker J. On the therapeutic value of adrenal cortical hormones in traumatic shock and allied conditions. Can Med Assoc J 1940;43:1-8
6. Sapolsky RM, Romero M, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000;21:55-89
7. Liao J, Keiser J, Scales W, Kunkel S, Kluger M. Role of corticosterone in TNF and IL-6 production in isolated perfused rat liver. Am J Physiol 1995;268:R699-R706
8. Eastman H, Fawcett T, Udelsman R, Holbrook N. Effects of perturbations of the hypothalamic-pituitary-adrenal axis on the acute phase response: altered C/EBP and acute phase response gene expression in lipopolysaccharide-treated rats. Shock 1996;6:286-92
9. Petrovsky N, Socha L, Silva D, Grossman A, Metz C, Bucala R. Macrophage migration inhibitory factor exhibits a pronounced circadian rhythm relevant to its role as a glucocorticoid counterregulator. Immunol Cell Biol 2003;81:137-43
10. Zeger SL, Liang KY, Albert PS. Models for longitudinal data: a generalized estimating equation approach. Biometrics 1988;44:1049 - 60
11. Fraser CG, Preuss FS, Bigford WD. Adrenal atrophy and irreversible shock associated with cortisone therapy. J Am Med Assoc 1952;149:1542-3
12. Laue L, Lotze M, Chrousos GP, Barnes K, Loriaux DL, Fleisher TA. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man; Toxicity, immunological, and hormonal aspects. J Clin Endocrinol Metab 1990;71:1474-80
13. Bertagna X, Escourolle H, Pinquier JL, Coste J, Raux-demay MC, Perles P, Silvestre L, Luton JP, Strauch G. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. J Clin Endocrinol Metab 1994;78:375-80
14. Allolio B, Schulte HM, Kaulen D, Reincke M, Jaursch-Hancke C, Winkelmann W. Nonhypnotic low-dose etomidate for rapid correction of hypercortisolaemia in Cushing's Syndrome. Klin Wochenshr 1988;66:361-4
15. de Jong F, Mallios C, Jansen C, Scheck P, Lamberts S. Etomidate suppresses andrenocortical function by inhibition of 11-- hydroxylation. J Clin Endocrinol Metab 1984;59 1143-7
16. Oelkers W, Diederich S, Bahr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone. J Clin Endocrinol Metab 1992;75:259-64
17. Liu JH, Garzo VG, Yen SS. Pharmacodyamics of the antiprogesterone RU486 in women after oral administration. Fertil Steril 1988;50:245-9
18. Moore RA, Allen MC, Wood PJ, Rees LH, Sear JW. Peri-operative endocrine effects of etomidate. Anaesthesia 1985;40:124-30
19. Duthie DJ, Fraser R, Nimmo WS. Effect of induction of anaesthesia with etomidate on corticosteroid synthesis in man. Br J Anaesth 1985;57:156-9
20. Goulding NJ. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Curr Opin Pharmacol 2004;4:629-36
21. Preziosi P, Vacca M. Mini review: andrenocortical suppression and other endocrine effects of etomidate. Life Sci 1988;42:477-789
22. Englelhardt D, Weber M. Therapy of Cushing's Syndrome with steroid biosynthesis inhibitors. J Steroid Biochem Mol Biol 1994;49:261-7
23. Loop T, Liu Z, Humar M, Hoetzel A, Benzing A, Pahl H, Geiger K, J Pannen B. Thiopental inhibits the activation of nuclear factor kappaB. Anesthesiology 2002;96:1202-13
24. Krumholz W, Reussner D, Hempelmann G. The influence of several intravenous anesthetics on the chemotaxis of human monocytes in vitro. Eur J Anaesth 1999;16:547-9
25. Larsen B, Hoff G, Wilhelm W, Buchinger H, Wanner G, Bauer M. Effect of intravenous anesthetics on spontaneous and endotoxin-stimulated cytokine response in cultured human whole blood. Anesthesiology 1998;89:1218-27
26. Kelbel I, Weiss M. Anaesthetics and immune function. [Review]. Curr Opin Anaesthesiol 2001;14:685-91
27. Shipman GF, Bloomfield CD, Gajl-Peczalska K, Munck AU, Smith KA. Glucocorticoids and lymphocytes. III. Effects of glucocorticoid administration on lymphocyte glucocorticoid receptors. Blood 1983;61:1086-90
28. Vachier I, Roux S, Chanez P, Loubatiere J, Terouanne B, Nicolas JC, Godard P. Glucocorticoids induced down-regulation of glucocorticoid receptor mRNA expression in asthma. Clin Exp Immunol 1996;103:311-5
29. Dong Y, Poellinger L, Gustafsson JA, Okret S. Regulation of glucocorticoid receptor expression: evidence for transcriptional and posttranslational mechanisms. Mol Endocrinol 1988;2:1256-64
30. Silva CM, Powell-Oliver FE, Jewell CM, Sar M, Allgood VE, Cidlowski JA. Regulation of the human glucocorticoid receptor by long-term and chronic treatment with glucocorticoid. Steroids 1994;59:436-42
31. Burnstein KL, Bellingham DL, Jewell CM, Powell-Oliver FE, Cidlowski JA. Autoregulation of glucocorticoid receptor gene expression. Steroids 1991;56:52-8
32. Salkowski CA, Vogel S. Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity. J Immunol 1992;149:4041-7
33. Sulahian TH, Pioli PA, Wardwell K, Guyre PM. Cross-linking of FcgammaR triggers shedding of the hemoglobin-haptoglobin scavenger receptor CD163. J Leukoc Biol 2004;76:271-7
34. Tiemessen MM, Jagger AL, Evans HG, van Herwijnen MJC, John S, Taams LS. CD4- CD25- Foxp3- regulatory T cells induce alternative activation of human monocytes/macrophages. Proc Natl Acad Sci U S A 2007;104:19446-51
35. Yeager MP, Rassias AJ, Fillinger MP, Discipio AW, Gloor KE, Gregory JA, Guyre PM. Cortisol antiinflammatory effects are maximal at postoperative plasma concentrations. Crit Care Med 2005;33:1507-12
36. van der Poll T, Barber AE, Coyle SM, Lowry SF. Hypercortisolemia increases plasma interleukin- 10 concentrations during human endotoxemia - a clinical research center study. J Clin Endocrinol Metab 1996;81:3604-6
37. Croker BA, Krebs DL, Zhang J-G, Wormald S, Willson TA, Stanley EG, Robb L, Greenhalgh CJ, Fö rster I, Clausen BE, Nicola NA, Metcalf D, Hilton DJ, Roberts AW, Alexander WS. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 2003;4:540-5
38. Daewoong J, Liu D, Yao S, Collins RD, Hawiger J. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nature Med 2005;11:892-8
39. Qin H, Wilson CA, Roberts KL, Baker BJ, Zhao X, Benveniste EN. IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J Immunol 2006;177:7761-71
40. Li Y, Chu N, Rostami A, Zhang GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 2006;177:1679-88
41. Gasperini S, Crepaldi L, Calzetti F, Gatto L, Berlato C, Bazzoni F, Yoshimura A, Cassatella MA. Interleukin-10 and cAMPelevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal. Eur Cytokine Netw 2002;13:47-53
42. Paul C, Seiliez I, Thissen JP, LeCam A. Regulation of expression of the rat SOCS-3 gene in hepatocytes by growth hormone, interleukin-6 and glucocorticoids mRNA analysis and promoter characterization. Eur J Biochem 2000;267:5849-57
43. Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, Benveniste EN. Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J Immunol 2007;179:5966-76
44. Calandra T, Bernhagen J, Metz CN, Splegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995;377:68-71
45. Wiegers G, Reul J. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol Sci 1998;19:317-21
46. Zhang T, Daynes R. Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway. J Immunol 2007;178:2517-26
47. Sulahian TH, Hogger P, Wahner AE, Wardwell K, Goulding NJ, Sorg C, Droste A, Stehling M, Wallace PK, Morganelli PM, Guyre PM. Human monocytes express CD163, which is upregulated by IL-10 and identical to p155. Cytokine 2000;12:1312-21
48. Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Landis RC. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte- responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004;9:119-26